Skip to main content
. 2021 May 28;9:673395. doi: 10.3389/fcell.2021.673395

TABLE 1.

Clinical trials on gut–brain axis in PD.

Study Drugs Phase Status NCT number
Investigate the digestive microbiota and bacterial translocation during IBD and PD Not applicable Recruiting NCT04159727
Treatment is able to restore the gut microbiota Rifaximin Phase 2 Recruiting NCT03958708
Resistant maltodextrin for gut microbiome in Parkinson’s disease Maltodextrin Phase 2 Recruiting NCT03667404
Brain–gut–microbiota axis and initiation of α-syn misfolding Not applicable Not yet recruiting NCT03710668
Gut-derived neuropeptides in cerebrospinal fluid of patients with Parkinson’s disease and healthy controls Certain gut-derived peptides (ghrelin, GLP-1) Completed NCT01792193
Effects of resistant starch on bowel habits, fecal short chain fatty acids and gut microbiota in Parkinson disease (RESISTA-PD) Resistant starch Completed NCT02784145
Study of the genome, gut metagenome and diet of patients with incident Parkinson’s disease (16S rRNA gene sequencing) Recruiting NCT04119596
Increased gut permeability to lipopolysaccharides (LPS) in Parkinson’s disease Completed NCT01155492
Possible role of bacteria of the nose and gut in the pathogenesis of PD Completed NCT01536769
Role of gut flora in Parkinson’s disease Recruiting NCT04148326
Gut microbiota across early stages of synucleinopathy Recruiting NCT03645226
Parkinson’s disease and digestive health (neuroenteric dysfunction) Recruiting NCT04032262
Probiotics-prebiotic fiber therapy in Parkinson’s disease patients with constipation Probiotics with prebiotic Phase 3 Completed NCT04451096
Study of the fecal microbiome in patients with Parkinson’s disease PRIM-DJ2727 Phase 1 Recruiting NCT03671785
Dietary intervention and gastrointestinal function in patients with Parkinson’s disease (MED) Mediterranean diet Not applicable Active, not recruiting NCT03851861
Fecal microbiota transplantation for Parkinson’s disease Recruiting NCT03808389
Study of the enteric nervous system using colonic biopsies in Parkinson patients with LRRK2 mutation (EnteroLarc) Terminated (lack of patients) NCT01618383